The Effects of Central Ghrelin on Serum Parameters Related to Energy Metabolism in Neonatal Chicks

Document Type : Reproduction - Physiology


1 Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman (SBUK), Kerman, Iran

2 Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman, Kerman, Iran.

3 Department of Clinical Sciences, Faculty of Veterinary Medicine, University of Shiraz, Shiraz, Iran

4 Department of Basic Sciences, Faculty of Veterinary Medicine, Shahid Bahonar University of Kerman ,Kerman, Iran

5 Nouroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

6 Department of Biochemistry, National Cerebral and Cardiovascular Centre Research Institute, 6-1 Kishibe-Shinmachi, Suita, Osaka 564-8565, Japan


BACKGROUND: Ghrelin is a regulatory peptide with endocrine and metabolic effects in mammals and birds.

OBJECTIVES: The aim of this study was to investigate the possible effects of intracerebroventricular (ICV) in-jection of ghrelin on the plasma level of some hormones and biochemical indices involved in the energy balance of neonatal chicks.

METHODS: Intracerebroventricular injection of 20 or 40 pmol ghrelin/individual was done. Blood samples were collected from the jugular vein 15 and 30 minutes after the ICV injection of ghrelin to measure serum parameters.

RESULTS: The ICV administration of 20 and 40 pmol ghrelin/individual had no effects at 15 min post-injection, but at 30 min post-injection, the triiodothyronine (T3) level significantly decreased in a dose-dependent manner. The leptin level also declined significantly compared to that of the control group. There were no significant changes in other parameters, including insulin, T4, triglyceride, cholesterol, and glucose.

CONCLUSIONS: It can be concluded that the changes that occurred in T3 and leptin levels may have been due to the effects of ghrelin on the metabolic rate and food intake (concerning T3) and the parallel action of ghrelin and leptin (concerning leptin).


Article Title [فارسی]

اثرات گرلین مرکزی برپارامترهای سرمی مرتبط با متابولیسم انرژی در جوجه های نوزاد

Authors [فارسی]

  • لادن عمادی 1
  • حسین جنیدی 2
  • سعید نظیفی 3
  • حامد خواستی 4
  • الهه روحانی 5
  • هیروکی کایا 6
1 گروه علوم پایه دانشکده دامپزشکی، دانشگاه شهید باهنر کرمان، کرمان، ایران
2 گروه علوم پایه ،دانشکده دامپزشکی، دانشگاه شهید باهنر کرمان، کرمان، ایران
3 گروه علوم درمانگاهی، دانشکده دامپزشکی، دانشگاه شیراز، شیراز، ایران
4 گروه علوم پایه دانشکده دامپزشکی، دانشگاه شهید باهنر کرمان، کرمان، ایران
5 مرکز تحقیقات علوم اعصاب، موسسه نوروفارماکولوژی، دانشگاه علوم پزشکی کرمان، کرمان، ایرا ن
6 گروه بیوشیمی، موسسه مرکزی تحقیقات مغزی و قلب ی- عروقی ملی، اوساکا، ژاپن
Abstract [فارسی]

زمینه مطالعه: گرلین پپتید تنظیمی است که اثرات اندوکرینی و متابولیک در پستانداران و پرندگان دارد.
هدف: هدف از این مطالعه بررسی اثرات احتمالی تزریق درون بطن مغزی گرلین بر میزان پلاسمایی برخی هورمونها و شاخص های بیوشیمیایی درگیر در بالانس انرژی جوجه های نوزاد می باشد.
روش کار: تجویز درون بطن مغزی 20 یا 40 پیکو مول گرلین به ازاء هر قطعه جوجه انجام شد و نمونه خون از سیاهرگ وداج، 15 و 30 دقیقه پس از تزریق درون بطن مغزی گرلین برای اندازه گیری پارامترهای سرمی جمع آوری گردید.
نتایج: جوجه تجویز درون بطن مغزی 20 و 40 پیکو مول گرلین به جوجه، 15 دقیقه پس از تزریق تاثیری نداشته، اما 30 دقیقه پس از تزریق سبب کاهش معنادار میزان تری یدوتیرونین بصورت وابسته به دوز شد. همچنین میزان لپتین بطور معنادار در مقایسه با گروه کنترل کاهش یافت. تغییر معناداری در سایر پارامترها، شامل انسولین، تیروکسین، تری گلیسرید، کلسترول و گلوکز وجود نداشت.
نتیجه گیری نهایی: چنین نتیجه گیری می شود که تغییرات رخ داده در میزان تری یدوتیرونین و لپتین ممکن است در نتیجه تاثیرات گرلین بر میزان متابولیسم و میزان اخذ غذا ( در نتیجه اثر تری یدوتیرونین) و فعالیت موازی گرلین و لپتین ( با توجه به اثر لپتین) باشد.

Keywords [فارسی]

  • مرکزی
  • متابولیسم انرژی
  • گرلین
  • جوجه های نوزاد
  • پارامترهای سرمی



Ghrelin, an acylated twenty-eight-amino acid orexigenic peptide hormone, was firstly identified in the rat stomach. Ghrelin also exists in various vertebrate species, including birds (Vizcarra, Wright & Vizcarra, 2012), secreted mainly from the proventriculus (Kaiya, Kangawa & Miyazato, 2013). It is involved in various physiological actions, such as regulating pituitary hormones, appetite, food intake, lipid metabolism, and energy expenditure (Abdalla, 2015). Ghrelin in chickens consists of 26 amino acids; this hormone has been identified in numerous bird species, such as chicken, turkey (Ceron-Romero et al., 2021), duck, and Japanese quail (Kaiya et al., 2002; Kaiya et al., 2008).

Evidence revealed that the central administration of ghrelin could stimulate growth hormone (GH) release and food intake in rats. Interestingly, in birds, the central and peripheral administration of either humans' or chicken's ghrelin stimulated the GH release, while its central, but not peripheral, injection strongly inhibited food intake (Tschöp, Smiley & Heiman, 2000; Lin and Sun, 2012; Müller et al., 2015).

It has been documented that ghrelin is expressed in rat-specific cell types of the anterior pituitary gland, such as somatotrophs, lactotrophs, and thyrotrophs. This evidence shows that ghrelin may act in a paracrine-like fashion to regulate the anterior pituitary gland cell function (Caminos et al., 2003). The expression of ghrelin in thyroid C cells and the presence of its receptor in follicular thyroid cells suggest that ghrelin regulates thyroid function in a paracrine manner (Mano-Otagiri et al., 2009). Functional ghrelin receptor (GHS-R1a) was predominantly expressed in the pituitary gland and, at much lower levels, in the thyroid gland, pancreas, spleen, myocardium, and adrenal gland. Ghrelin modulates energy expenditure affecting the Hypothalamus-Hypophysis-Thyroid axis (HPT axis) (Dos-Santos et al., 2019).

Leptin is released from the adipose tissue, where it acts as a signal between the peripheral lipid stores and the central nervous system. Chicken leptin protein contains three cysteine residues containing two cysteine residues in mammals. Leptin is expressed not only in the adipose tissue but also in the liver and plays a significant role in regulating food intake and energy balance. Leptin inhibits food intake both in mammals and birds (Lõhmus et al., 2003). The exogenous administration of (species) leptin decreases the number of orexigenic peptides (anabolic effectors) and increases the anorexigenic peptides (catabolic effectors), resulting in the reduction of food intake. The leptin gene expression is sensitive to hormonal treatment in the liver, where the major source of leptin, but not in the adipose tissue in chickens (Ashwell et al., 1999).

To date, the effects of ghrelin on serum parameters involved in energy hemostasis have not been examined in chicks. The present study was aimed to evaluate the changes in some biochemical serum parameters, such as triiodothyronine (T3), thyroxin (T4), leptin, insulin, glucose, triglyceride, and cholesterol, after the intracerebroventricular (ICV) injection of ghrelin in neonatal chicks.

Materials and Methods


One day-old-male Ross broiler chicks were obtained from Mahan hatchery (Kerman, Iran). House temperature was kept at 30°C, and humidity was controlled at 45-50%. A continuous lighting regimen was provided to the birds throughout the experimental period. The broilers were fed with a commercial basal diet (21% protein and 2,900 kcal metabolizable energy). Diets in mash form and water were provided ad libitum throughout the experimental period.

On the day prior to the injection, the chicks were placed in individual cages, and 6-day-old chicks were selected for ICV injection.

ICV Injection

Customly synthesized octanoylated chicken ghrelin, with 26 amino acids (GSS (n-octanoyl) FLSPTYKNIQQQKDTRKPTARLH, ASBIO Pharma Co. Ltd., Japan)), was used in this study. Ghrelin was dissolved in 5% mannitol solution to prevent the absorption of peptides to the wall of the tube or syringes, and 0.1% Evans Blue. This solution was also used as a control. ICV injections were done in a volume of 5 μg by using a microsyringe, as described by Furuse (Furuse et al., 1997), without anesthesia. Briefly, the head of each chick was held with an acrylic device in which the bill holder was 45°, and the calvarium was parallel to the surface of the table. The injection was performed through a hole in the plate overlying the skull immediately over the right lateral ventricle. Then, a microsyringe was inserted into the right lateral ventricle through the hole, and the test solution was injected. The top of the needle was penetrated 3-4 mm below the skull's skin. This procedure appeared not to induce any physiological stress (Saito et al., 2005).


Before each experiment, the birds were weighed and distributed into experimental groups based on their body weight so that the average weight between the treatment groups would be as uniform as possible.

At the end of the experiment, inhalation anesthesia was induced in chicks by exposure to ether gas, and then birds' decapitation was carried out. The correct injection was confirmed by the presence of Evans Blue dye in the lateral ventricle. Birds with no dye trace in the lateral ventricle region were not used for data analysis.

Experiment 1: The chicks were divided into three groups, including six animals. Group 1 (control) included the animals which received 5% mannitol solution with 0.1% Evans Blue. Group 2 and 3 received 20 and 40 pmol ghrelin/individual, respectively. Blood samples were collected from the jugular vein 15 minutes after the ICV injection and transferred to vacuum tubes. Blood samples were then centrifuged, and their serum was obtained and stored at -20°C until serum T3, T4, triglyceride, total cholesterol, glucose, insulin, and leptin were taken.

Experiment 2: The second experiment was similar to the first, except that the blood sample collection was done 30 minutes post-injection.


Measurement of Biochemical Parameters

Serum T3 and T4 levels were measured using the Iran Padtan-Elm competitive ELISA kit with a minimum sensitivity of 0.5 ng/mL and 0.4 μ g/dL, respectively. The serum leptin and insulin levels were measured using commercial chicken-specific ELISA kits using a quantitative sandwich enzyme immunoassay (Shanghai Crystal Day Biotech, Shanghai, China).

The sensitivity of the insulin kit was 0.59 μIU/mL. The intra- and inter-assay precision of the insulin kit were CV < 15%. The sensitivity of the leptin kit was 0.078 ng/mL. The intra- and inter-assay precision of the leptin kit were CV < 8% and CV < 10%, respectively.

Serum biochemical analyses included glucose, cholesterol, and triglyceride, which were determined using commercial kits (Pars Azmoon Kits, Iran) and a biochemical auto-analyzer (Alpha Classic AT++, Sanjesh Company, Iran). All measurements were done based on the instructions provided by the manufacturer regarding the use of kits.

Statistical Analyses

The data were expressed as mean ± SEM. Statistical analysis was performed using a one-way analysis of variance by the general linear modeling procedure. Tukey's multiple range tests used comparisons between the treatment groups. The level of significance was P-value≤0.05.


In experiment 1, the ICV administration of ghrelin had no significant effects on any of the parameters at 15 minutes after the injection compared to the control group (Table 1). In experiment 2, where blood was collected 30 minutes after the injection, serum T3 level decreased significantly in a dose-dependent manner. Also, serum leptin levels declined significantly compared to that of the control group. Meanwhile, there were no significant changes between the experimental groups with regard to other parameters, including triglyceride, cholesterol, insulin, glucose, and T4 (Table 2).





Table 1. Biochemical serum parameters (mean ± SEM) at 15 min after the ICV injection of ghrelin (20 and 40 pmol) in broiler chicks

15 minutes after injection






Glucose (mg/dL)


















Ghrelin 20 pmol









Ghrelin 40 pmol










Table 2. Biochemical serum parameters (mean ± SEM) at 30 min after the ICV injection of ghrelin (20 and 40 pmol) in broiler chicks

30 minutes after injection






Glucose (mg/dL)

















Ghrelin 20 pmol

1.23±0.031 a






1.23±0.059 a

Ghrelin 40 pmol

1.07±0.028 ab






1.04±0.056 a

a: A significant difference was observed in the control group at the 30 minute.

ab: A significant difference was observed in the 20 pmol ghrelin group at the 30 minute.




One of the functional differences between rodents and birds regarding ghrelin is that this peptide enhances the utilization of carbohydrates in rats and mice to promote energy conservation in their fat tissues (Tschöp et al., 2000; Thompson et al., 2004). In contrast, ghrelin reduces the accumulation of fat stores in chickens by the down-regulation of the mRNA level of a lipogenic enzyme, fatty acid synthase (FAS), and its transcription factors in the liver (Buyse et al., 2009). There is a relationship between the amount of subcutaneous fat stores and restlessness during migration in migrating birds. More activity and migratory restlessness seem to be associated with larger fat stores in birds. In this situation, the birds migrate faster and stay shorter at stopovers (Kokkinos et al., 2007; Eikenaar and Schläfke, 2013). There is little doubt that circulating ghrelin concentrations reflect body fat stores. It has been reported that high ghrelin levels reduce the accum-ulation of fat stores and activate the breakdown of lipids in the liver of fat individuals. This is necessary for migration because fat is the primary fuel for migrating birds (Sjöberg et al., 2015). It may be true that serum ghrelin levels increase at the onset of migration.

It has also been reported that in small rodents, the injection of ghrelin increases blood glucose, reduces glucose tolerance, and restricts insulin secretion via direct action on the pancreatic islets of Langerhans (Caminos et al., 2003). This is not in agreement with the present study's findings because no changes were observed in the serum levels of glucose and insulin in the neonatal chicks in the present study. Previous reports have shown that the central and subcutaneous administration of ghrelin or GHS injection increases the respiratory quotient (RQ), decreases fat oxidation, increases the expression of fat-storage enzymes in white adipose tissue, and induces weight gain in rodents (Tschöp et al., 2000; Tschöp et al., 2002; Theander-Carrillo et al., 2006). In contrast, peripheral ghrelin administration significantly decreased the RQ values for up to 14 h in one-week-old broiler chickens (Tschöp et al., 2000; Tschöp et al., 2002). Similar to our findings, ghrelin had no effect on the levels of plasma glucose and triglyceride in small rodents, when injected peripherally (Tschöp et al., 2000; Tschöp et al., 2002).

Leptin, which is an anorexigenic hormone that is produced by white adipose tissue, decreases food intake and energy expenditure by the direct activation of POMC/CART neurons and inhibition of NPY-/AgRP neurons, resulting in a reduction in body weight. Central infusion of leptin agonists has been shown to have a beneficial effect on glucose homeostasis, as leptin infusion can decrease abdominal fat, increase insulin sensitivity, and decrease hepatic glucose production (Tschöp et al., 2000). Blood leptin levels are positively correlated with adiposity. Therefore, leptin may be considered an indicator reflecting body energy stores, which link fat deposits to the central nervous system. It has been shown that leptin expression in chickens, as in mammals, is regulated by hormonal and nutritional status (Lin & Sun, 2012). The blood leptin levels are regulated by the nutritional state, with high levels in the fed state compared to the fasted state in chickens.

ccording to the literature, enhancing the circulating GH in chickens can depress food intake (Mano-Otagiri et al., 2009). In chickens, chronic GH infusion increases leptin expression in the liver but not in the adipose tissue (Kokkinos et al., 2007). GH has a direct effect on leptin is not concomitant with a decrease in food intake. Avian adipose tissue seems to be refractory to insulin, dexamethasone, and GH. This absence of adipose tissue responsiveness may be explained by a constitutive leptin expression in this tissue and/or by the role of adipose tissue, which is considered as a storage site versus the liver as the primary site of lipogenesis, in avian species. Thus, it can be concluded that the reduction of leptin observed in the present study may be due to ghrelin-induced food inhibition and/or the direct effect of ghrelin on the liver.

It is worth noting that the leptin administration did not affect agouti-related peptide (AGRP) and proo-piomelanocortin (POMC), orexigenic, and anorexigenic peptides that are expressed in the hypoth-alamic arcuate nucleus and corticotrophin-releasing hormone (CRH), an anorexigenic/catabolic neuropeptide which is expressed in the hypothalamic paraventricular nucleus, respectively, in neonatal chicks. Also, it must be added that the effects of AGRP were not the same on different strains of chicken; it stimulated food intake in the layer but not in the broiler chicks (Tachibana et al., 2001).

It has been shown that fasting and a β3-adrenoreceptor agonist suppress the synthesis of leptin in rodents and humans (Koutkia et al., 2003). It has also been demonstrated that the central administration of ghrelin suppresses the activity of the sympathetic nerve of the brown adipose tissue (BAT) in rats. It is noteworthy that ghrelin induces hypophagia via a β2-adrenergic receptor in chickens (Zendehdel & Hassanpour, 2014). Based on these findings, the reduced serum level of leptin in the present invest-igation could be attributed to the effects of ghrelin on the sympathetic system in chicks

The activation of the Hypothalamic-Pituitary-Thyroid (HPT) axis stimulates the metabolic rate of some tissues such as liver, heart, muscle, and adipose tissue, thereby increasing thermogenesis and energy expenditure (Mano-Otagiri et al., 2009; Kaiya, Miyazato & Kangawa, 2011). The ICV injection of ghrelin decreased the activity of the HPT axis in rats; as a result, the thyrotrophic cells in the anterior pituitary became smaller, the TSH plasma level was lower, the thyroid follicles were less active, and the thyroxin (T4) plasma level was reduced (Tachibana et al., 2006). This result is in agreement with that of the present study, in which it was observed that ghrelin reduced the HPT function in chicks by reducing the T3 serum level. This is the first observation of the effect in birds. In vitro investigations have shown that ghrelin increases the TSH-induced proliferation of rat thyrocytes (Lin & Sun, 2012). Although it was initially reported that the elevation of thyroid hormones in humans was induced by the ghrelin action on the thyroid gland, where the ghrelin receptor has been identified to be present. Subsequent studies showed that ghrelin did not change plasma TSH level either in dogs or humans (St-Pierre et al., 2004; Bhatti et al., 2006). These findings suggest that ghrelin may act through the binding sites, which are different from the GHS-R detected in the human thyroid gland (Tachibana et al., 2006; Dos-Santos et al., 2019). It appears that there is a correlation between thyroid functional status and ghrelin plasma level. To support this hypothesis, it was observed that plasma ghrelin levels decreased and increased in hyperthyroid and hypothyroid rats, respectively (Caminos et al., 2002). Thus, increased food intake in hyperthyroid rats can be regulated through other pathways, which in turn, can inhibit the release of ghrelin. In such situation, the changes in the ghrelin level which correlate to the thyroid function state could reflect a transition to a more energy-efficient metabolic state, finally leading to a positive energy balance (Inoue et al., 2013).

In some studies, it was observed that the leptin infusion decreased the plasma T3 and glucose levels in chickens as a consequence of lowered food intake (Dridi et al., 2005; Theander-Carrillo et al., 2006). Ghrelin induces the release of glucocorticoids both in chickens and mammals (Inoue et al., 2013). In chickens, GH and glucocorticoids are involved in the generation of the active thyroid hormone triiodothyronine (T3); glucocorticoids are also involved in the production of T3 via the up-regulation of type II deiodinase enzyme in the brain (Kühn et al., 2005). The intravenous injection of GH in chickens resulted in an increased T3 plasma concentration during the post-hatch growth period (Inoue et al., 2013) Therefore, it can be stated that ghrelin, due to its GH-releasing effect, may also influence the thyroid function. However, the results of the present study show a decrease in T3, which is the opposite result. We don't know at present why this is the case.


In conclusion, based on the results of this study, it can be concluded that increased ghrelin levels in the brain of chicks can lead to a reduction in the plasma level of leptin. Neither the physiological importance nor the underlying mechanism of this effect is clear yet. However, this function of ghrelin can be attributed to its inhibitory effect on food intake and/or its direct effect on the liver. Furthermore, the influence of central ghrelin on the sympathetic system may interfere with its action on the leptin secretion. However, as observed in small rodents, the central ghrelin reduced the serum T3 level in chickens in this study, and this effect of ghrelin may be related to its influence on food intake and the metabolic function.


The authors thank the Research Council of Shahid Bahonar University of Kerman for the financial support of this study.

Conflict of Interest

The authors declare that they have no conflict of interest.



Ashwell, C. M., Czerwinski, S. M., Brocht, D. M., & McMurtry, J. P. (1999). Hormonal Regulation of Leptin Expression in Broiler Chickens. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology276(1), R226-R232.    DOI:10.1152/ajpregu.1999.276.1.R226] [PMID]
Bhatti, S. F. M., De Vliegher, S. P., Mol, J. A., Van Ham, L. M. L., & Kooistra, H. S. (2006). Ghrelin-Stimulation Test in the Diagnosis of Canine Pituitary Dwarfism. Research in Veterinary Science81(1), 24-30. [DOI:10.1016/j.rvsc.2005.09.009] [PMID]
Buyse, J., Janssen, S., Geelissen, S., Swennen, Q., Kaiya, H., Darras, V. M., & Dridi, S. (2009). Ghrelin Modulates Fatty Acid Synthase and Related Transcription Factor mRNA levels in a Tissue-Specific Manner in Neonatal Broiler Chicks. Peptides30(7), 1342-1347. [DOI:10.1016/j.peptides.2009.04.015] [PMID]
Caminos, J. E., Nogueiras, R., Blanco, M., Seoane, L. M., Bravo, S., Alvarez, C. V., ... & Dieguez, C. (2003). Cellular Distribution and Regulation of Ghrelin Messenger Ribonucleic Acid in the Rat Pituitary Gland. Endocrinology144(11), 5089-5097.            [DOI:10.1210/en.2003-0529] [PMID]
Caminos, J. E., Seoane, L. M., Tovar, S. A., Casanueva, F. F., & Dieguez, C. (2002). Influence of Thyroid Status and Growth Hormone Deficiency on Ghrelin. European Journal of Endocrinology147(1), 159-163. [DOI:10.1530/eje.0.1470159] [PMID]
Ceron-Romero, N., Taofeek, N., Thomas, A., Vroonland, E., Sanmartin, K., Verghese, M., ... & Vizcarra, J. A. (2021). Capromorelin, a Ghrelin Receptor Agonist, Increases Feed Intake and Body Weight Gain in Broiler Chickens (Gallus gallus domesticus). Poultry Science, 101204. [DOI:10.1016/j.psj.2021.101204] [PMID] [PMCID]
Dos‐Santos, R. C., Reis, L. C., Perello, M., Ferguson, A. V., & Mecawi, A. S. (2019). The Actions of Ghrelin in the Paraventricular Nucleus: Energy Balance and Neuroendocrine Implications. Annals of the New York Academy of Sciences1455(1), 81-97.          [DOI:10.1111/nyas.14087] [PMID]
Dridi, S., Swennen, Q., Decuypere, E., & Buyse, J. (2005). Mode of Leptin Action in Chicken Hypothalamus. Brain Research1047(2), 214-223.         [DOI:10.1016/j.brainres.2005.04.034] [PMID]
Eikenaar, C., & Schläfke, J. L. (2013). Size and Accumulation of Fuel Reserves at Stopover Predict Nocturnal Restlessness in a Migratory Bird. Biology Letters9(6), 20130712. [DOI:10.1098/rsbl.2013.0712] [PMID] [PMCID]
Furuse, M., Matsumoto, M., Saito, N., Sugahara, K., & Hasegawa, S. (1997). The Central Corticotropin-Releasing Factor and Glucagon-like Peptide-1 in Food Intake of the Neonatal Chick. European Journal of Pharmacology339(2-3), 211-213.  [DOI:10.1016/S0014-2999(97)01391-5]
Inoue, Y., Nakahara, K., Maruyama, K., Suzuki, Y., Hayashi, Y., Kangawa, K., & Murakami, N. (2013). Central and Peripheral Des-Acyl Ghrelin Regulates Body Temperature in Rats. Biochemical and Biophysical Research Communications430(1), 278-283.. [DOI:10.1016/j.bbrc.2012.10.137] [PMID]
Kaiya, H., Miyazato, M., & Kangawa, K. (2011). Recent Advances in the Phylogenetic Study of Ghrelin. Peptides32(11), 2155-2174. [DOI:10.1016/j.peptides.2011.04.027] [PMID]
Kaiya, H., Miyazato, M., Kangawa, K., Peter, R. E., & Unniappan, S. (2008). Ghrelin: A Multifunctional Hormone in Non-Mammalian Vertebrates. Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology149(2), 109-128.    [DOI:10.1016/j.cbpa.2007.12.004] [PMID]
Kaiya, H., Van Der Geyten, S., Kojima, M., Hosoda, H., Kitajima, Y., Matsumoto, M., ... & Kangawa, K. (2002). Chicken Ghrelin: Purification, cDNA Cloning, and Biological Activity. Endocrinology143(9), 3454-3463. [DOI:10.1210/en.2002-220255] [PMID]
Kaiya, H., Kangawa, K., & Miyazato, M. (2013). Update on Ghrelin Biology in Birds. General and Comparative Endocrinology190, 170-175.         [DOI:10.1016/j.ygcen.2013.04.014] [PMID]
Kokkinos, A., Mourouzis, I., Kyriaki, D., Pantos, C., Katsilambros, N., & Cokkinos, D. V. (2007). Possible Implications of Leptin, Adiponectin and Ghrelin in the Regulation of Energy Homeostasis by Thyroid Hormone. Endocrine32(1), 30-32. [DOI:10.1007/s12020-007-9002-5] [PMID]
Koutkia, P., Canavan, B., Johnson, M. L., DePaoli, A., & Grinspoon, S. (2003). Characterization of Leptin Pulse Dynamics and Relationship to Fat Mass, Growth Hormone, Cortisol, and Insulin. American Journal of Physiology-Endocrinology and Metabolism285(2), E372-E379. [DOI:10.1152/ajpendo.00097.2003] [PMID]
Kühn, E. R., Geelissen, S. M. E., Van der Geyten, S., & Darras, V. M. (2005). The Release of Growth Hormone (GH): Relation to the Thyrotropic-and Corticotropic Axis in the Chicken. Domestic Animal Endocrinology29(1), 43-51.         [DOI:10.1016/j.domaniend.2005.02.022] [PMID]
Lin, L., & Sun, Y. (2012). Thermogenic Characterization of Ghrelin Receptor Null Mice. Methods in Enzymology514, 355-370. [DOI:10.1016/B978-0-12-381272-8.00022-2] [PMID]
Lõhmus, M., Sundström, L. F., El Halawani, M., & Silverin, B. (2003). Leptin Depresses Food Intake in Great Tits (Parus Major). General and Comparative Endocrinology131(1), 57-61.DOI:10.1016/S0016-6480(02)00643-3]
Mano-Otagiri, A., Ohata, H., Iwasaki-Sekino, A., Nemoto, T., & Shibasaki, T. (2009). Ghrelin Suppresses Noradrenaline Release in the Brown Adipose Tissue of Rats. Journal of Endocrinology201(3), 341.   [DOI:10.1677/JOE-08-0374] [PMID]
Abdalla, M. M. I. (2015). Ghrelin–Physiological Functions and Regulation. European Endocrinology11(2), 90.        [DOI:10.17925/EE.2015.11.02.90] [PMID] [PMCID]
Müller, T. D., Nogueiras, R., Andermann, M. L., Andrews, Z. B., Anker, S. D., Argente, J., ... & Tschöp, M. H. (2015). Ghrelin. Molecular Metabolism4(6), 437-460. [DOI:10.1016/j.molmet.2015.03.005] [PMID] [PMCID]
Saito, E. S., Kaiya, H., Tachibana, T., Tomonaga, S., Denbow, D. M., Kangawa, K., & Furuse, M. (2005). Inhibitory Effect of Ghrelin on Food Intake is Mediated by the Corticotropin-Releasing Factor System in Neonatal Chicks. Regulatory Peptides125(1-3), 201-208. [DOI:10.1016/j.regpep.2004.09.003] [PMID]
Sjöberg, S., Alerstam, T., Åkesson, S., Schulz, A., Weidauer, A., Coppack, T., & Muheim, R. (2015). Weather and Fuel Reserves Determine Departure and Flight Decisions in Passerines Migrating Across the Baltic Sea. Animal Behaviour104, 59-68.    [DOI:10.1016/j.anbehav.2015.02.015]
St-Pierre, D. H., Karelis, A. D., Cianflone, K., Conus, F., Mignault, D., Rabasa-Lhoret, R., ... & Poehlman, E. T. (2004). Relationship Between Ghrelin and Energy Expenditure In Healthy Young Women. The Journal of Clinical Endocrinology & Metabolism89(12), 5993-5997. [DOI:10.1210/jc.2004-0613] [PMID]
Tachibana, T., Kaiya, H., Denbow, D. M., Kangawa, K., & Furuse, M. (2006). Central Ghrelin Acts as an Anti-Dipsogenic Peptide in Chicks. Neuroscience Letters405(3), 241-245.     [DOI:10.1016/j.neulet.2006.07.019] [PMID]
Tachibana, T., Sugahara, K., Ohgushi, A., Ando, R., Kawakami, S. I., Yoshimatsu, T., & Furuse, M. (2001). Intracerebroventricular Injection of Agouti-Related Protein Attenuates the Anorexigenic Effect of Alpha-Melanocyte Stimulating Hormone in Neonatal Chicks. Neuroscience Letters305(2), 131-134.     [DOI:10.1016/S0304-3940(01)01827-4]
Theander-Carrillo, C., Wiedmer, P., Cettour-Rose, P., Nogueiras, R., Perez-Tilve, D., Pfluger, P., ... & Rohner-Jeanrenaud, F. (2006). Ghrelin Action in the Brain Controls Adipocyte Metabolism. The Journal of Clinical Investigation116(7), 1983-1993. [DOI:10.1172/JCI25811] [PMID] [PMCID]
Thompson, N. M., Gill, D. A., Davies, R., Loveridge, N., Houston, P. A., Robinson, I. C., & Wells, T. (2004). Ghrelin and Des-Octanoyl Ghrelin Promote Adipogenesis Directly in Vivo by a Mechanism Independent of the Type 1a Growth Hormone Secretagogue Receptor. Endocrinology145(1), 234-242.            [DOI:10.1210/en.2003-0899] [PMID]
Tschöp, M., Smiley, D. L., & Heiman, M. L. (2000). Ghrelin Induces Adiposity in Rodents. Nature407(6806), 908-913. [DOI:10.1038/35038090] [PMID]
Tschöp, M., Statnick, M. A., Suter, T. M., & Heiman, M. L. (2002). GH-Releasing Peptide-2 Increases fat Mass in Mice Lacking NPY: Indication for a Crucial Mediating Role of Hypothalamic Agouti-Related Protein. Endocrinology143(2), 558-568.           [DOI:10.1210/endo.143.2.8633] [PMID]
Vizcarra, J. A., Wright, H., & Vizcarra, A. (2012). The effect of Passive Immunization Against Ghrelin on Feed and Water Intake in Turkeys. Poultry Science91(9), 2305-2309. DOI:10.3382/ps.2012-02206] [PMID]
Zendehdel, M., & Hassanpour, S. (2014). Ghrelin-Induced Hypophagia is Mediated by the β 2 Adrenergic Receptor in Chicken. The Journal of Physiological Sciences64(5), 383-391. [DOI:10.1007/s12576-014-0330-y] [PMID].